Molecular analysis of melatonin-induced changes in breast cancer cells: Microarray study of anti-cancer effect of melatonin

Biochip Journal

Volumn 5, Issue 4, 2011, Pages 353-361

  Lee, Seung Eun ^a   Kim, Seung Jun ^b   Yang, Hana ^a   Jeong, Seong Il ^a   Hwang, Seung Yong ^b,c   Park, Cheung Seog ^a   Park, Yong Seek ^a  

^a Kyung Hee University Hospital   (South Korea)

^b GenoCheck Co Ltd   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Anti cancer effect; Breast cancer; Gene expression profile; MCF 7; Melatonin

Indexed keywords

BIOLOGICAL SYSTEMS; CELL ADHESION; CELL DEATH; CELL PROLIFERATION; CHEMICAL ANALYSIS; DISEASES; GENE THERAPY; HORMONES; ONTOLOGY; TUMORS;

ANTI-CANCER EFFECT; BREAST CANCER; GENE EXPRESSION PROFILE; MCF-7; MELATONIN;

GENE EXPRESSION;

MELATONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE ONTOLOGY ENRICHMENT ANALYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; TRANSLATION REGULATION; UPREGULATION;

EID: 82755170434     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-011-5409-4     Document Type: Article

References (41)

1. Arendt, J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev. Reprod. 3, 13-22 (1998).
2. Pevet, P., Bothorel, B., Slotten, H. & Saboureau, M. The chronobiotic properties of melatonin. Cell Tissue Res. 309, 183-191 (2002).
3. Dollins, A. B., Zhdanova, I. V., Wurtman, R. J., Lynch, H. J. & Deng, M. H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. USA91, 1824-1828 (1994).
4. Carrillo-Vico, A. et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and antiapoptotic effects. J. Pineal Res. 39, 400-408 (2005).
5. Paradies, G., Petrosillo, G., Paradies, V., Reiter, R. J. & Ruggiero, F. M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal. Res. 48, 297-310 (2010).
6. Petrosillo, G., Moro, N., Paradies, V., Ruggiero, F. M. & Paradies, G. Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin. J. Pineal Res. 48, 340-346 (2010).
7. Reiter, R. J. et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 52, 11-28 (2007).
8. Hill, S. M. et al. Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther. 8, 337-346 (2009).
9. Joo, S. S. & Yoo, Y. M. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J. Pineal Res. 47, 8-14 (2009).
10. Karbownik, M., Lewinski, A. & Reiter, R. J. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int. J. Biochem. Cell Biol. 33, 735-753 (2001).
11. Reiter, R. J. Melatonin: clinical relevance. Best Pract. Res. Clin. Endocrinol. Metab. 17, 273-285 (2003).
12. Blask, D. E. et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65, 11174-11184 (2005).
13. Cini, G. et al. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. J. Pineal Res. 39, 12-20 (2005).
14. Lee, S. E. et al. MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect. J. Pineal Res. 51, 345-352 (2011).
15. Cos, S. & Blask, D. E. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res. 17, 25-32 (1994).
16. Cos, S. & Sanchez-Barcelo, E. J. Melatonin and mammary pathological growth. Front Neuroendocrinol21, 133-170 (2000).
17. Martinez-Campa, C. et al. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br. J. Cancer101, 1613-1619 (2009).
18. Girgert, R., Hanf, V., Emons, G. & Grundker, C. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J. Pineal Res. 47, 23-31 (2009).
19. Cucina, A. et al. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J. Pineal Res. 46, 172-180 (2009).
20. Huangda, W. et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35, W169-175 (2007).
21. Pandi-Perumal, S. R., Srinivasan, V., Spence, D. W. & Cardinali, D. P. Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs21, 995-1018 (2007).
22. Tan, D. X. et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2, 181-197 (2002).
23. Futagami, M., Sato, S., Sakamoto, T., Yokoyama, Y. & Saito, Y. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells. Gynecol. Oncol. 82, 544-549 (2001).
24. Leja-Szpak, A., Jaworek, J., Pierzchalski, P. & Reiter, R. J. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J. Pineal Res. 49, 248-255 (2010).
25. Martin-Renedo, J. et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal Res. 45, 532-540 (2008).
26. Um, H. J. & Kwon, T. K. Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells. J. Pineal Res. 49, 283-290 (2010).
27. Blask, D. E., Dauchy, R. T. & Sauer, L. A. Putting cancer to sleep at night-The neuroendocrine/circadian melatonin signal. Endocrine27, 179-188 (2005).
28. Mediavilla, M. D., Cos, S. & Sanchez-Barcelo, E. J. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65, 415-420 (1999).
29. Cos, S., Fernandez, R., Guezmes, A. & Sanchez-Barcelo, E. J. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58, 4383-4390 (1998).
30. Jacobsen, J. et al. Catalytic properties of ADAM12 and its domain deletion mutants. Biochemistry47, 537-547 (2008).
31. Dyczynska, E., Syta, E., Sun, D. & Zolkiewska, A. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. Int. J. Cancer122, 2634-2640 (2008).
32. Stautz, D. et al. ADAM12 localizes with c-Src to actinrich structures at the cell periphery and regulates Src kinase activity. Exp. Cell Res. 316, 55-67 (2010).
33. Rizzotti, M. et al. The effect of extracellular matrix modifications on UDP-glucose dehydrogenase activity in cultured human skin fibroblasts. Basic Appl. Histochem. 30, 85-92 (1986).
34. Auvinen, P. et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 156, 529-536 (2000).
35. Huh, J. W. et al. Inhibition of human UDP-glucose dehydrogenase expression using siRNA expression vector in breast cancer cells. Biotechnol. Lett. 27, 1229-1232 (2005).
36. Hwang, E. Y. et al. Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity. FEBS Lett. 582, 3793-3797 (2008).
37. Lee, S. E. et al. Uncaria rhynchophylla induces heme oxygenase-1 as a cytoprotective effect in RAW 264. 7 macrophages. Mol. Cell. Toxicol. 6, 33-40 (2010).
38. Jeong, S. I. et al. Toxicologic evaluation of bacterial synthesized cellulose in endothelial cells and animals. Mol. Cell. Toxicol. 6, 373-380 (2010).
39. Yang, H. et al. Expression profile analysis of human umbilical vein endothelial cells treated with salvianolic acid B from Salvia miltiorrhiza. BioChip J. 5, 47-55 (2011).
40. Jeong, S. I. et al. Genome-wide analysis of gene expression by crotonaldehyde in human umbilical vein endothelial cells. Mol. Cell. Toxicol. 7, 129-136 (2011).
41. Lee, S. E. et al. Methylglyoxal-mediated alteration of gene expression in human endothelial cells. BioChip J. 5, 220-228 (2011).